Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial (Q34374835)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial |
scientific article |
Statements
1 reference
Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial (English)
1 reference
1 reference
John R Mascola
1 reference
David C Montefiori
1 reference
Barton F Haynes
1 reference
Merlin L Robb
1 reference
Nelson L Michael
1 reference
Jerome H Kim
1 reference
Supachai Rerks-Ngarm
1 reference
Raphael Gottardo
1 reference
Georgia D Tomaras
1 reference
Peter Gilbert
1 reference
Sorachai Nitayaphan
1 reference
Punnee Pitisuttithum
1 reference
Steve Self
1 reference
Susan Zolla-Pazner
1 reference
Phillip W Berman
1 reference
Faruk Sinangil
1 reference
James Tartaglia
1 reference
Kelli Greene
1 reference
Ellen Turk
1 reference
Robert T Bailer
1 reference
Joshua Phillips
1 reference
Xiaoying Shen
1 reference
Gregory Imholte
1 reference
Larry Eckler
1 reference
Holger Wenschuh
1 reference
Johannes Zerweck
1 reference
Hongmei Gao
1 reference
Donald Francis
1 reference
Carter Lee
1 reference
26 September 2013
1 reference
26 September 2013
1 reference
limma R package
1 reference
1 reference
1 reference
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference